May 23, 2024, 14:25
Benjamin Besse: Should we infuse IO in the morning?
Benjamin Besse, Head of Clinical Research on Gustave Roussy, shared on X:
“Should we infuse IO in the morning? Intriguing work just published: Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy. .
We may need to analyze timing of IO infusion in phase III trials to guide us in our daily clinic.”
Read further.
Source: Benjamin Besse/X
Jul 26, 2024, 06:20